Fox Run Management’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Fox Run Management's BLTE Position: Q3 2026 in Review
Fox Run Management opened a new position in Belite Bio (BLTE) in Q3 2026: 1,914 shares worth $325K. The stake represents 0.04% of the portfolio and ranks #733 among its holdings.
96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Fox Run Management held 1,914 shares of Belite Bio worth $325K as of Q3 2026.
- Belite Bio was a new Fox Run Management position in Q3 2026.
- Belite Bio made up 0.04% of Fox Run Management's portfolio in Q3 2026, its #733 holding.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.